The role of Fas in autoimmune diabetes

Cell

Volumn 89, Issue 1, 1997, Pages 17-24

  Chervonsky, Alexander V ^a   Wang, Yi ^c   Wong, F Susan ^a   Visintin, Irene ^a   Flavell, Richard A ^a,b   Janeway Jr , Charles A ^a,b   Matis, Louis A ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c ALEXION PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; ETIOLOGY; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALIA; MUS MUSCULUS;

EID: 0030890721     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80178-6     Document Type: Article

References (47)

1. Adachi, M., Watanabe-Fukunaga, R., and Nagata, S. (1993). Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of Ipr mice. Proc. Natl. Acad. Sci. USA 90, 1756-1760.
2. Alderson, M.R., Tough, T.W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K.A., Goodwin, R.G., Smith, C.A., Ramsdell, K., and Lynch, D.H. (1995). Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181, 71-77.
3. Allen, R.D., Marshall, J.D., Roths, J.B., and Sidman, C.L. (1990). Differences defined by bone marrow transplantation suggest that Ipr and gld are mutations of genes encoding an interacting pair of molecules. J. Exp. Med. 172, 1367-1375.
4. Allison, J., Malcolm, L.,Culvenor, J., Bartolomeusz, R.K., Holmberg, K., and Miller, J.F. (1991). Overexpression of beta 2-microglobulin in transgenic mouse islet beta cells results in defective insulin secretion. Proc. Natl. Acad. Sci. USA 88, 2070-2074.
5. André, I., Gonzalez, A., Wang, B., Katz, J., Benoist, C., and Mathis, D. (1996). Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. USA 93, 2260-2263.
6. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., and Duke, R.C. (1995). A role for CD95 ligand in preventing graft rejection. Nature 377, 630-632.
7. Chirgwin, J.M., Prxybyla, A.E., MacDonald, R.J., and Rutter, W.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched with ribonuclease. Biochemistry 18, 5294-5299.
8. Dhein, J., Walczak, H., Baumler, C., Debatin, K.M., and Krammer, P.H.(1995). Autocrine T cell suicide mediated by APO-1/(Fas/CD95). Nature 375, 78-81.
9. Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middleton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J., and Puck, J.M. (1995). Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946.
10. Gilette-Ferguson, I., and Sidman, C.L. (1994). A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune Ipr and gld mice. Eur. J. Immunol. 24, 1181-1188.
11. Griffith, T.S., Brunner, T., Fletcher, S.M., Green, D.R., and Ferguson, T.A. (1995). Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192.
12. Guerder, S., Picarella, D.E., Linsley, P.S., and Flavell, R.A. (1994). Costimulator B7-1 confers antigen presenting cell function to parenchymal tissue and in conjunction with tumor necrosis factor-α leads to auto-immunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91, 5138-5142.
13. Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Screier, M., French, L.E., Schneider, P., Bornard, T., Fontana, A., Lienard, D., Cerottini, J.-C., and Tschopp, J. (1996). Melanoma cells expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274, 1363-1366.
14. Hamaguchi, K., Gaskins, H.R., and Leiter, E.H. (1991). NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 40, 842-849.
15. Han, H.S., Jun, H.S., Utsugi, T., and Yoon, J.W. (1996). A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J. Autoimmun. 9, 331-339.
16. Hanahan, D. (1985). Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 375, 115-122.
17. Hughes, D.P.M., and Crispe, I.N. (1995). A naturally occurring isoform of murine Fas generated by alternative splicing. J. Exp. Med. 182, 1395-1401.
18. Janeway, C.A., Jr., Haque, S., Smith, L.A., and Saizawa, K. (1987). The role of the m urine L3T4 molecule in T cell activation: differential effects of anti-L3T4 on activation by monoclonal anti-receptor antibodies. J. Mol. Cell. Immunol. 3, 121-131.
19. Klas, C., Debatin, K.M., Jonker, R.R., and Krammer, P.H. (1993). Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5, 625-630.
20. Lau, H.T., Yu, M., Fontana, A., and Stoeckert, C.J., Jr. (1996). Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273, 109-112.
21. Ledbetter, J.A., and Herzenberg, L.A. (1979). Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47, 63-90.
22. Lenschow, D.J., Herold, K.C., Rhee, L., Patel, B., Koons, A., Qin, H.-Y., Fuchs, E., Singh, B., Thompson, C.B., and Bluestone, J.A. (1996). CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5, 285-293.
23. Lo, D., Burkly, L.C., Widera, G., Cowing, C., Flavell, R.A., Palmiter, R.D., and Bristner, R.L. (1988). Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 53, 159-168.
24. Lynch, D.H., Watson, M.L., Alderson, M.R., Baum, P.R., Miller, R.E., Tough, T., Gibson, M., Davis-Smith, T., Smith, C.A., Hunter, K., et al. (1994). The mouse Fas-ligand gene is mutated in gld mice and is a part of a TNF family gene cluster. Immunity 1, 131-136.
25. Murphy, E.D., and Roths, J.B. (1978). Autoimmunity and lymphoproliferation: induction by mutant gene Ipr, and alteration by a male-associated factor in strain BXSB mice. In Genetic Control of Autoimmune Disease, N.R. Rose, P.E. Bigazzi, and N.L. Warner, eds. (North-Holland, Amsterdam: Elsevier), pp. 207-221.
26. Nagata, S., and Golstein, P. (1995). The Fas death factor. Science 267, 1449-1457.
27. + cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. J. Immunol. 152, 2042-2050.
28. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S. (1993). Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809.
29. Ramsdell, F., Seaman, M.S., Miller, R.E., Picha, K.S., Kennedy, M.K., and Lynch, D.H. (1994). Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6, 1545-1553.
30. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I.A.G., Debatin, K.M., Fischer, A., and de Villartay, J.P. (1995). Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349.
31. Rouvier, E., Luciani, M.-F., and Golstein, P. (1993). Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195-200.
32. Russell, J.H., Rush, B., Weaver, C., and Wang, R. (1993). Mature T cells of autoimmune Ipr/Ipr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 90, 4409-4413.
33. Stassi, G., Todaro, M., Trucco, G., Rudert, W., De Maria, R., Richiusa, P., Mattina, A., Galluzzo, A., Trucco, M., and Giordano, C. (1996). Human insulin-producing beta-cells dye through Fas-mediated apoptosis. Autoimmunity 24, Suppl. 1, 6.
34. Strand, S., Hofmann, W.J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S.M., Stremmel, W., Krammer, P.H., and Galle, P.R. (1996). Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nature Med. 2, 1361-1366.
35. Takahashi, T., Tanaka, M., Brannan, C.I., Jenkins, N.A., Copeland, N.G., Suda, T., and Nagata, S. (1994). Generalized lyymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-977.
36. Takahashi, H., Kobayashi, H., Hashimoto, Y., Matsuo, S., and Iizuka, H. (1995). Interferon-gamma-dependent stimulation of Fas antigen in SV40-transformed human keratinocytes: modulation of the apoptotic process by protein kinase C. J. Invest. Dermatol. 105, 810-815.
37. Tisch, R., and McDevitt, H. (1996). Insulin-dependent diabetes mellitus. Cell 85, 291-297.
38. Trauth, B.C., Klas, C., Peters, A.M., Matzku, S., Moller, P., Falk, W., Debatin, K.M., and Krammer, P.M. (1989). Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305.
39. Vignaux, F., and Golstein, P. (1994). Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 24, 923-927.
40. Vyse, T.J., and Todd, J.A. (1996). Genetic analysis of autoimmune disease. Cell 85, 311-318.
41. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., and Nagata, S. (1992a). Lymphoprolipheration disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-318.
42. Watanabe-Fukunaga, R., Brannan, C.I., Itoh, N., Yonehara, S., Copeland, N.G., Jenkins, N.A., and Nagata, S. (1992b). The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279.
43. Wicker, L.S., Todd, J.A., and Peterson, L.B. (1995). Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13, 179-200.
44. Wong, F.S., Visintin, I., Wen, L., Flavell, R.A., and Janeway, C.A., Jr. (1996). CDS T cell clones can transfer diabetes in NOD mice in the absence of CD4 T cells. J. Exp. Med. 183, 67-76.
45. Yagita, H., Seino, K.-I., Kayagaki, N., and Okumura, K. (1996). CD95 ligand in graft rejection. Nature 379, 682.
46. Yamada, K., Takane-Gyotoku, N., Yuan, X., Ichikawa, F., Inada, C., and Nonaka, K. (1996). Mouse islet cell lysis mediated by interleukin-1 induced Fas. Diabetologia 39, 1306-1312.
47. Yonehara, S., Ishii, A., and Yonehara, M. (1989). A cell-killing monoclonal antibody(anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.